China Moves to Tighten Export Controls on AI, Biopharma and Solar Technologies Amid Rising Western Tensions

Chinese regulators have proposed tightening oversight of overseas sales of several cutting-edge technologies, signaling a new front in Beijing’s effort to manage the outward flow of strategically sensitive know-how as frictions with Western governments persist.

Authorities said on Friday they intend to expand China’s export control list to cover certain technologies related to artificial intelligence, biopharmaceuticals and photovoltaics—the core technologies behind solar power systems. The stated goal is to prevent specific capabilities from “proliferating inappropriately,” language that points to worries about national security, competitive advantage and the downstream use of advanced tools abroad.

The move comes as China and major Western economies continue to clash over technology access and supply-chain security. Export controls—once focused primarily on physical goods—have increasingly become a tool for governing intangible assets such as algorithms, specialized processes and high-value manufacturing methods that can be difficult to monitor but are central to modern industrial competitiveness.

China’s push to restrict exports of AI-related technologies arrives at a moment when the country is showcasing and accelerating development in the field. The World Artificial Intelligence Conference, a major industry and policy gathering, was held in Shanghai in July, underscoring how prominently AI features in China’s economic and strategic planning. By moving to place parts of the sector under export controls, Beijing is signaling it may treat some AI capabilities as sensitive technologies whose overseas transfer requires closer scrutiny.

Biopharmaceutical technologies are also included in the proposed expansion. This reflects the growing importance of biotech and drug development as areas tied not only to commercial growth but also to public health resilience and strategic autonomy—especially as governments worldwide weigh how much to depend on cross-border supply chains for critical medical products and research capabilities.

Photovoltaic technologies, which sit at the heart of solar energy, round out the list of sectors that Chinese authorities want to bring under tighter export governance. China plays an outsized role in global solar manufacturing and supply, and the inclusion of photovoltaic technology suggests Beijing is seeking to manage the dissemination of expertise and methods that contribute to that dominance.

The proposal illustrates how export controls are becoming a central feature of the ongoing “tech tensions” between China and Western countries. While the announcement does not detail precisely which sub-technologies would be covered or how approvals would be administered, it indicates Beijing’s intent to more actively regulate the international transfer of advanced capabilities in several high-value industries.

Why it matters

Companies operating across borders in AI, biotech and solar may face new compliance steps and potential delays as China broadens export controls into more technology categories. The decision also adds another layer to global tech decoupling pressures, as governments increasingly treat innovation and know-how as strategic assets. Watch for the final scope of the controls and how trading partners respond, particularly in sectors where China is a critical supplier.